المؤلفون: Reis, Samuel Roosevelt Campos dos, Quixada, Acy Telles de Souza, Nunes, Sammara Tavares, Cid, Danielle Maria Camelo, Souza, Jacqueline Holanda de, Costa, Clara Maria Bastos Eloy da, Silveira, Carolina Bizelli, Cid, David Antonio Camelo, Oliveira, Mariana Fatima Cabral de

المصدر: Revista Brasileira de Hematologia e Hemoterapia. June 2013 35(3)

مصطلحات موضوعية: Leukemia, myelogenous, chronic, BCR-ABL positive/drug therapy, Piperazines/therapeutic use, Medication adherence, Fusion Proteins, bcr-abl/genetic, Treatment outcome

وصف الملف: text/html

URL الوصول: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000300174

المؤلفون: Samuel Roosevelt Campos dos Reis, Acy Telles de Souza Quixada, Sammara Tavares Nunes, Danielle Maria Camelo Cid, Jacqueline Holanda de Souza, Clara Maria Bastos Eloy da Costa, Carolina Bizelli Silveira, David Antonio Camelo Cid, Mariana Fatima Cabral de Oliveira

المصدر: Revista Brasileira de Hematologia e Hemoterapia, Vol 35, Iss 3, Pp 174-179 (2013)

مصطلحات موضوعية: Leukemia, myelogenous, chronic, BCR-ABL positive/drug therapy, Piperazines/therapeutic use, Medication adherence, Fusion Proteins, bcr-abl/genetic, Treatment outcome, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000300174&lng=en&tlng=en; https://doaj.org/toc/1806-0870

URL الوصول: https://doaj.org/article/0d66fd5bf0f94927b70ccc5b5f2ff2ed

المؤلفون: Acy Telles de Souza Quixadá, Mariana Fatima Cabral de Oliveira, Sammara Tavares Nunes, Danielle Maria Camelo Cid, David Antonio Camelo Cid, Samuel Roosevelt Campos dos Reis, Clara Maria Bastos Eloy da Costa, Carolina Bizelli Silveira, Jacqueline Holanda de Souza

المصدر: Revista Brasileira de Hematologia e Hemoterapia, Volume: 35, Issue: 3, Pages: 174-179, Published: JUN 2013
Dos Reis, S R C, Quixadá, A T D S, Nunes, S T, Cid, D M C, de Souza, J H, da Costa, C M B E, Silveira, C B, Cid, D A C & de Oliveira, M F C 2013, ' Adherence to treatment with imatinib in chronic myeloid leukemia: a study of the first decade of responses obtained at a Brazilian hospital ', Revista brasileira de hematologia e hemoterapia, vol. 35, no. 3, pp. 174-9 . https://doi.org/10.5581/1516-8484.20130053
Revista Brasileira de Hematologia e Hemoterapia, Vol 35, Iss 3, Pp 174-179 (2013)
Revista Brasileira de Hematologia e Hemoterapia
Revista Brasileira de Hematologia e Hemoterapia v.35 n.3 2013
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC

مصطلحات موضوعية: Drug, medicine.medical_specialty, media_common.quotation_subject, Population, Disease, Leukemia, myelogenous, chronic, BCR-ABL positive/drug therapy, hemic and lymphatic diseases, Internal medicine, medicine, Journal Article, Treatment outcome, education, Psychiatry, Medication adherence, media_common, education.field_of_study, business.industry, lcsh:RC633-647.5, Fusion Proteins, bcr-abl/genetic, Advanced stage, Myeloid leukemia, Imatinib, Hematology, lcsh:Diseases of the blood and blood-forming organs, Piperazines/therapeutic use, Imatinib mesylate, Major Molecular Response, Original Article, business, medicine.drug

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::571dc23426c8fc0e9a61ed2f418539e1
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000300174&lng=en&tlng=en

المؤلفون: Dos Reis SR; Universidade Federal do Ceará, UFC, Fortaleza, CE, Brazil., Quixadá AT, Nunes ST, Cid DM, de Souza JH, da Costa CM, Silveira CB, Cid DA, de Oliveira MF

المصدر: Revista brasileira de hematologia e hemoterapia [Rev Bras Hematol Hemoter] 2013; Vol. 35 (3), pp. 174-9.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Brazil NLM ID: 101220159 Publication Model: Print Cited Medium: Print ISSN: 1516-8484 (Print) Linking ISSN: 15168484 NLM ISO Abbreviation: Rev Bras Hematol Hemoter Subsets: PubMed not MEDLINE